Filter by: patients
What is Conjugated estrogens-medroxyprogesterone?

A hormone combination of conjugated estrogens and medroxyprogesterone acetate, is used in women for treatment of moderate-to-severe symptoms associated with menopause; for the treatment of atrophic vaginitis; and as preventative for ososteoporosis.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Menopause 11 1 Efficacy_major
Other 9 2 Efficacy_cant_tell
Hot flashes 6 0
General health 5 0
Bone Pain 2 1 Efficacy_cant_tell
Keep me balanced/hormonial 1 0

See all 30 patients currently taking Conjugated estrogens-medroxyprogesterone

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
0
Moderate
0
Mild
1
None
7

Commonly reported side effects, conditions, and hospitalizations associated with Conjugated estrogens-medroxyprogesterone

Hot flashes 1

Reported Dosages

  daily 0.0,625 mg daily 0.45 mg daily 0.3 mg-1.5 mg m,w,f 0.625 mg-2.5 mg m,w,f 0.3 mg-1.5 mg daily 0.45 mg-1.5 mg daily 0.625 mg-2.5 mg daily 0.625 mg-5 mg daily 2 x 0.625 mg-2.5 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 7 Number of Patients: 7 3 Number of Patients: 3 9 Number of Patients: 9 3 Number of Patients: 3 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Conjugated estrogens-medroxyprogesterone (multiple reasons could be selected)
Reason # Patients Percentage of patients
Personal research 4   Personal research: 33%
Doctor's advice 4   Doctor's advice: 33%
Expense 3   Expense: 25%
Other 3   Other: 25%
Course of treatment ended 1   Course of treatment ended: 8%

See all 11 patients who’ve stopped taking Conjugated estrogens-medroxyprogesterone

Currently Taking Conjugated estrogens-medroxyprogesterone

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0

Stopped Taking Conjugated estrogens-medroxyprogesterone

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Conjugated estrogens-medroxyprogesterone

Always
6 75%
Usually
1 13%
Sometimes
0 0%
Never
1 13%

Burden

Difficulty being on treatment

Burden of Conjugated estrogens-medroxyprogesterone

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
8 100%

Cost

Paid out of pocket

Cost of Conjugated estrogens-medroxyprogesterone

$200+
0 0%
$100-199
0 0%
$50-99
1 14%
$25-49
3 43%
< $25
3 43%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 28, 2012.